Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report)’s share price traded up 19.6% during trading on Tuesday . The company traded as high as $1.9726 and last traded at $1.9726. Approximately 4,000 shares traded hands during trading, an increase of 27% from the average session volume of 3,150 shares. The stock had previously closed at $1.65.
Mayne Pharma Group Price Performance
The firm has a 50-day simple moving average of $1.65 and a 200-day simple moving average of $1.80.
About Mayne Pharma Group
Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.
In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.
Further Reading
- Five stocks we like better than Mayne Pharma Group
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
